Legal Opinion
Eli Lilly and Co. v. SICOR PHARMACEUTICALS, INC.
District Court, S.D. Indiana
Decided March 31, 2010No. 1:06-mj-00238PublishedCited by 4 opinions
1Opinion of the Court
FINDINGS OF FACT AND CONCLUSIONS OF LAW
SARAH EVANS BARKER, District Judge.
This matter is before the Court for decision following a trial on the issues of validity, enforceability, and infringement of two patents held by Plaintiff Eli Lilly and Company (“Lilly”): United States Patent Nos. 4,808,614 (“the '614 patent”) and 5,464,826 (“the '826 patent”). The '614 patent covers the compound gemcitabine, and the '826 patent covers the method of treating susceptible neoplasms in mammals with gemcitabine. Lilly markets gemcitabine for injection under the trade-name GEMZAR®, which is approved for the…
2Cases cited76 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- Blonder-Tongue Laboratories, Inc. v. University of Illinois FoundationSupreme Court of the United States · 1971
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Rivet v. Regions Bank of LouisianaSupreme Court of the United States · 1998
- The Barbed Wire PatentSupreme Court of the United States · 1892
71 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- Alcon Research Ltd. v. Barr Laboratories Inc.District Court, D. Delaware · 2011
- United Therapeutics Corp. v. Watson Laboratories, Inc.District Court, D. Massachusetts · 2016
- Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co.Court of Appeals for the Federal Circuit · 2010
- Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co.Court of Appeals for the Federal Circuit · 2010